AXA and Microsoft build digital healthcare platform

By Leila Hawkins
AXA and Microsoft have built a digital healthcare platform to to offer e-services to customers

Multinational insurance company AXA is working with Microsoft to build a digital healthcare platform that simplifies user's healthcare journeys with a fully integrated ecosystem.

The partnership will combine AXA’s global reach and extensive experience in healthcare and insurance, business and technology architecture skills, with Microsoft's deep expertise in cloud-based computing and artificial intelligence.

The new platform will rely on Microsoft Cloud for Healthcare's portfolio of technology including Azure API for FHIR (Fast Healthcare Interoperability Resources), that enables patient insights without compromising patient privacy.

The range of services offered will include a self-assessment and prevention tool, a medical concierge, a teleconsultation interface, a digital document vault, home care services (e.g. medicine delivery) and a directory of healthcare professionals.

It will also be tailored to the needs of local health networks. A pilot program, which included a self-assessment tool, teleconsultation and a medical concierge to facilitate appointment-setting, was successfully launched in late 2020 in Germany and Italy.

In 2022 it will be launched in the United Kingdom, Belgium, Spain and Switzerland to be followed by other countries around the globe.

In the long term, the platform aims to allow integration of third-party services, with the ambition of creating an open, global service for healthcare providers and patients, regardless of whether they are AXA customers.


Featured Articles

WHO Health Chatbot Built on 'Humanised' GenAI

World Health Organisation's GenAI digital health tool is built using ‘AI humanisation’ tech & designed to ease burden on health workers & educate on health

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Costco move to partner with online healthcare provider Sesame to provide members with weight-loss drugs including Wegovy signals US anti-obesity boom

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

As it's announced AstraZeneca's CEO Pascal Soriot's package could rise by as much as US$24mn we explore the history of the UK's most valuable business

US Academic Medical Centres 'Struggling' says McKinsey


J&J Community Initiatives Tackle US Healthcare Chasm

Medical Devices & Pharma

PitchBook: Healthcare Private Equity Deals see Decline

Health Insurance & Finance